
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Xintela develops medical products in stem cell therapy and targeted cancer therapy based on the Companys cell surface marker integrin 101 which is found on mesenchymal stem cells and on certain aggressive cancer cells. The stem cell marker is used to select and quality-assure the patent-protected stem cell product XSTEM, which is in clinical development for treatment of knee osteoarthritis and difficult-to-heal leg ulcers. The company produces XSTEM for the clinical studies in its GMP-approved manufacturing facility. In cancer therapy, which is run by the wholly owned subsidiary Targinta AB, therapeutic antibodies, targeting integrin 101 (First-in-Class) are being developed for...
Alpha 10 marker technology,regenerative medicine,and cancer
Xintela ab operates in the Biotechnology research industry.
Xintela ab's revenue is < 1m
Xintela ab has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.